|
Tuesday,
April 29, 2003
United
States Patent and Trademark Office
Arlington,
Virginia 22202
Patent
Theater, Crystal Park 2, 2nd Floor
** Note New Location**
--SPECIAL
MEETING FOCUSING ON APPLICATION OF THE UTILITY AND WRITTEN DESCRIPTION
EXAMINATION GUIDELINES AND PRACTICES--
THIS PARTNERSHIP MEETING WILL FOCUS ON YOUR CONCERNS RELATING TO THESE CRITICAL AREAS OF PATENT PRACTICE. WE LOOK FORWARD TO HEARING YOUR CONCERNS AND ISSUES.
The most recent quarterly meeting for the Biotechnology and Chemical
Pharmaceutical Customer Partnership was held on January 14, 2003, at the U.S.
Patent and Trademark Office. The Biotechnology and Chemical Pharmaceutical Customer Partnership is
designed and developed to be a forum to share ideas, experiences, and insights
between individual users and the USPTO. The USPTO does not intend to use these customer partnership groups to
arrive at any consensus. Invitations to participate will indicate that individual opinions are
sought, rather than a group consensus and that the meetings are intended to be
informal in nature and have varying participants. These customer partnership groups are formed with full recognition of the
USPTO’s responsibility under the Federal Advisory Committee Act (FACA), and
that these customer partnership groups are not established as FACA compliant
committees.
We value our customers in obtaining feedback from individual participants is
important in our efforts to continuously improve the quality of our products and
services. Your willing participation is helpful in providing us with insights and
experiences in this informal process to assist us.
The next meeting of
the US Patent and Trademark Office Biotechnology and Chemical Pharmaceutical
Customer Partnership is scheduled for Tuesday , April 29, 2003 from 9:00
am to 4:30pm, Patent Theater, Crystal Park 2, 2nd Floor, located
on 2121 Crystal Drive, Arlington, Virginia.
Please contact Cecilia Tsang at 703-308-0254 or by fax at 703-746-7144 or email Cecilia.Tsang@uspto.gov
or contact Sharlamar Taliaferro at 703-306-4094 or by fax 703-305-8002 or email Sharlamar.Taliaferro@uspto.gov
to decline or confirm your attendance.
Biotechnology/Chemical/Pharmaceutical
Customer Partnership
Tuesday,
April 29, 2003
United States Patent and Trademark Office
Arlington, Virginia 22202
Patent Theater, Crystal Park 2, 2nd Floor
** Note New Location**
| Morning
Session |
| 9:00-9:15AM
|
Greetings
and Overview |
Jasemine
Chambers
John Doll
Bruce Kisliuk
Directors, TC 1600 |
| 9:15-9:30
AM |
Opening
Remarks |
Jon
Dudas, Deputy Under Secretary of Commerce for Intellectual Property
and Deputy Director of the USPTO. |
| 9:30-10:45
AM |
Town
Hall Meeting Part I "Utility" |
Steve
G. Kunin, Deputy Commissioner for Patent Examination Policy.
Esther M. Kepplinger, Deputy Commissioner for Patent Operations. |
| 10:45-11:00
AM |
Break |
|
| 11:00-12:15
PM |
Town
Hall Meeting Part II
"Written Description" |
Steve
G. Kunin, Deputy Commissioner for Patent Examination Policy.
Esther M. Kepplinger, Deputy Commissioner for Patent Operations. |
| 12:15
PM -1:45 PM |
Lunch
Break |
|
| Afternoon
Session |
| 1:45
- 2:45 PM |
ePhoenix
and ePair |
John
Doll &
Mary Small |
| 2:45
- 3:00 PM |
Break |
|
| 3:00
- 4:00 PM |
Priority
Claims |
Robert
Spar , OPLA |
| 4:00
- 4:15 PM |
Wrap
Up |
Jasemine
Chambers
John Doll
Bruce Kisliuk
Directors, TC 1600 |
|